Cold Chain issues? Unlike a traditional logistic solution, a cold chain independent, thermo stable solid form vaccines is a breakthrough solution.
Google search "MACIVIVA" see how this unknown otc SEC Filer microcap, MYMX led a consortium of 5 european companies including Catalent UK (NYSE: CTLT), Bachem (SWX: BANB), to successfully develop this process. This breakthrough platform is currently applied to the company's HIV vaccine in partnership with University of Louisiana, Lafayette's Iberia Research Center under NIH funding as well as its current in-house covid vaccine development program. The company is also in partnership with Baylor College of Medicine and recently with Insel Gruppe AG in developing a covid vaccine. News is imminent on status updates.
